arrow
K

Kyung-Jo Kim

University of Cambridge
H指数:35
被引数:4,049

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EFFICACY AND SAFETY OF OPEN-LABEL MAINTENANCE THERAPY WITH SUBCUTANEOUS RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE
2017-04-012
PREAI
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

选择性interleukin-23抑制剂risankizumab在中度至重度克罗恩病患者中的诱导治疗: 一项随机,双盲,安慰剂对照的2期研究

LANCET
IF88.5
2017-04-01364
OAAI
Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study
2017-03-2415
PREAI
Efficacy and Safety of Induction Therapy With the Selective IL-23 Inhibitor BI 655066, in Patients With Moderate-to-Severe Crohn's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study
2016-04-0110
PREAI